Fresenius Medical Care AG & Co. KGaA
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FMCQF research report →
Companywww.freseniusmedicalcare.com
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
- CEO
- Helen Giza
- IPO
- 2012
- Employees
- 112,035
- HQ
- Bad Homburg, DE
Price Chart
Valuation
- Market Cap
- $11.34B
- P/E
- 11.22
- P/S
- 0.54
- P/B
- 0.80
- EV/EBITDA
- 5.82
- Div Yield
- 3.74%
Profitability
- Gross Margin
- 25.96%
- Op Margin
- 10.17%
- Net Margin
- 4.88%
- ROE
- 7.16%
- ROIC
- 5.76%
Growth & Income
- Revenue
- $19.62B · 1.47%
- Net Income
- $977.63M · 81.75%
- EPS
- $3.35 · 83.06%
- Op Income
- $1.84B
- FCF YoY
- 4.64%
Performance & Tape
- 52W High
- $58.68
- 52W Low
- $42.00
- 50D MA
- $45.06
- 200D MA
- $48.03
- Beta
- 0.82
- Avg Volume
- 37
Get TickerSpark's AI analysis on FMCQF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FMCQF Coverage
We haven't published any research on FMCQF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FMCQF Report →